Article ID Journal Published Year Pages File Type
10484627 Value in Health 2014 9 Pages PDF
Abstract
Telaprevir plus PR in the Australian setting is cost-effective when compared with PR alone in patients infected with genotype 1 HCV.
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Authors
, , , , , , ,